Sowing the Seeds From Alabama to Brazil
Like the Deep South Network for Cancer Control, the Sowing the Seeds of Health program relies on community health advisors to spread the word about cancer prevention and early detection
Barriers to Mammogram Completion Persist Despite Insurance Coverage and Reminder Programs
New research suggested that concern about pain may deter obese women from undergoing mammography, while a busy schedule may dissuade women aged less than 60 years
Injection Laryngoplasty Is Effective for Laryngeal Dysfunction in Cancer Patients
New data suggest that office-based injection laryngoplasty (IL) appears to be a safe and effective treatment for laryngeal dysfunction in cancer patients.
Meta-Analysis Finds That Depression Is Not Inevitable in Cancer Patients
New data suggest that a diagnosis of cancer does not necessarily lead to depression.
Study Indicates That Immigrant Women in Ontario Shun Cervical Cancer Screening
New data suggest that immigration status may help explain why some women decide to be screened for cervical cancer and others do not
Imaging for Prostate Cancer Does Not Adhere to National Guidelines
According to a retrospective review of a SEER-Medicare database presented at the ASCO Genitourinary Cancers Symposium
Robotic-Assisted Laparoscopic Radical Prostatectomy Has Steep Learning Curve
Performing robotic-assisted laparoscopic radical prostatectomy (RALP) surgeries at an expert level is not as easy as has been previously assumed
Bicalutamide During and After Radiation Improves Progression-Free Survival in Men With Rising PSA Following Primary Surgery for Prostate Cancer
According to primary results of a phase III randomized, placebocontrolled trial reported at the 2011 ASCO Genitourinary Cancers Symposium
Everolimus Improves Progression-Free Survival in Patients with Previously Treated Metastatic RCC
A subgroup analysis of a randomized trial showed that patients with previously treated metastatic renal cell carcinoma had significant improvement in progression-free survival when they received everolimus.
Dutasteride Followed By Watchful Waiting May Delay Cancer Progression in Men With Early Prostate Cancer
Dutasteride, a drug commonly used to treat benign prostatic hyperplasia, may also be useful as part of a "watchful waiting" strategy
Study Presents Preliminary But Impressive Data In Metastatic Castration- Resistant Prostate Cancer
cabozantinib (XL184) - a novel wide-spectrum tyrosine kinase inhibitor (TKI) - achieved dramatic results in patients with castration-resistant prostate cancer
March 2011 FDA Updates
FDA updates for the Month of March
Excessive multivitamin consumption may be linked to prostate cancer
Though taking multivitamins has been linked to potential health benefits, a new study has found that an excessive consumption of multivitamins may not be beneficial.
The Final Word on CYP2D6 Testing and Tamoxifen?
CYP2D6 phenotype status does not predict tamoxifen efficacy in patients with early-stage breast cancer, according to a retrospective analysis of data from the Breast International Group
Shedding More Light on Identifying HER2
Breast cancer researcher Edith A. Perez, MD, is aiming to present more detailed study findings at national conferences later this year that will help clinicians better identify patients who would benefit from HER2 targeted treatment.
Announcing a New Partnership and an Opportunity for Growth
The John Theurer Cancer Center is proud to be partnering with Intellisphere to advance this mission by overseeing editorial content development and helping to provide in-depth content, new learning opportunities, and bestpractice approaches to cancer care.
Long-term effect of treatment on childhood cancer survivors
Recent reports published in the Childhood Cancer Survivor Study (CCSS) are examining the longterm or delayed health effects of cancer treatments.
Palliative care shows surprising benefit
New research has shown that adding prompt palliative supportive care to standard treatment may not only improve mood and quality of life in cancer patients, but it may even extend survival.
Crisis Averted? Manufacturers Scurry to Meet Demand for Drugs
The shortage, which began in 2009, accelerated in 2010, and has shown no signs of abatement so far in 2011, according to Erin R. Fox, PharmD, manager of the Drug Information Service at University of Utah Health Care
Brufsky Urges Caution in Translating Assays
Amid advances in gene-based cancer diagnostics, questions about the best use of molecular and cellular assays in practice are growing along with the new options for clinicians.
Benefit of Elacestrant Improves With Longer Duration of CDK4/6 Inhibition in Patients With ER+/HER2– Metastatic Breast Cancer
Lifileucel Induces Response in Metastatic Melanoma Independent of Number of IL-2 Doses Received
Rajkumar Previews CAR-T Updates, Elranatamab Findings in Multiple Myeloma Ahead of ASH 2022
Palbociclib Plus Fulvestrant Fails to Improve PFS in ER+/HER2- Breast Cancer After Progression on a CDK4/6 inhibitor
2 Clarke DriveSuite 100Cranbury, NJ 08512
© 2022 MJH Life Sciences™ and OncLive - Clinical Oncology News, Cancer Expert Insights. All rights reserved.